Related Experiment Video
Updated: Jun 25, 2025

Expanding the Comprehension of the Tumor Microenvironment using Mass Spectrometry Imaging of Formalin-Fixed and Paraffin-Embedded Tissue Samples
Published on: June 29, 2022
Development of a high dimensional imaging mass cytometry panel to investigate spatial organization of tissue
Stian Tornaas1, Dimitrios Kleftogiannis1,2, Siren Fromreide1
1Center for Cancer Biomarkers (CCBIO) and Department of Clinical Medicine, University of Bergen, Norway.
Insights
Imaging mass cytometry (IMC) enables detailed spatial analysis of the tumor microenvironment (TME). This study developed a robust antibody panel and bioinformatics pipeline for characterizing TME heterogeneity in head and neck cancer.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- Understanding tumor microenvironment (TME) composition and spatial interactions is crucial for cancer research.
- Imaging mass cytometry (IMC) offers high-parameter, subcellular resolution for multiparametric tissue analysis.
Purpose of the Study:
- To develop and validate a comprehensive antibody panel and analysis workflow for IMC.
- To characterize the heterogeneity of cancer-associated fibroblasts (CAFs) and other TME components in a spatial context.
Main Methods:
- Standardization and optimization of a 40-parameter antibody panel for IMC using FFPE tissues.
- Image segmentation with the Steinbock framework and unsupervised clustering using an R-based bioinformatics pipeline.
- Validation of the panel and workflow on head and neck squamous cell carcinoma (HNSCC) FFPE samples.
Main Results:
- A robust IMC antibody panel and bioinformatics pipeline were established for TME characterization.
- The method successfully resolved cellular heterogeneity and spatial relationships within the TME.
- The platform demonstrated effectiveness in analyzing FFPE tissues from HNSCC.
Conclusions:
- The developed IMC platform provides a powerful tool for dissecting TME complexity with spatial detail.
- This approach holds promise for investigating the clinical implications of TME heterogeneity in large patient cohorts.
- The standardized workflow facilitates the analysis of diagnostically relevant FFPE tissues in biobanks.
Abstract:
To decipher the interactions between various components of the tumor microenvironment (TME) and tumor cells in a preserved spatial context, a multiparametric approach is essential. In this pursuit, imaging mass cytometry (IMC) emerges as a valuable tool, capable of concurrently analyzing up to 40 parameters at subcellular resolution. In this study, a set of antibodies was selected to spatially resolve multiple cell types and TME elements, including a comprehensive panel targeted at dissecting the heterogeneity of cancer-associated fibroblasts (CAF), a pivotal TME component. This antibody panel was standardized and optimized using formalin-fixed paraffin-embedded tissue (FFPE) samples from different organs/lesions known to express the markers of interest. The final composition of the antibody panel was determined based on the performance of conjugated antibodies in both immunohistochemistry (IHC) and IMC. Tissue images were segmented employing the Steinbock framework. Unsupervised clustering of single-cell data was carried out using a bioinformatics pipeline developed in R program. This paper provides a detailed description of the staining procedure and analysis workflow. Subsequently, the panel underwent validation on clinical FFPE samples from head and neck squamous cell carcinoma (HNSCC). The panel and bioinformatics pipeline established here proved to be robust in characterizing different TME components of HNSCC while maintaining a high degree of spatial detail. The platform we describe shows promise for understanding the clinical implications of TMA heterogeneity in large patient cohorts with FFPE tissues available in diagnostic biobanks worldwide.
More Related Videos
11:00Visualization, Quantification, and Mapping of Immune Cell Populations in the Tumor Microenvironment
Published on: March 25, 2020
06:05Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment
Published on: June 2, 2023